EcoDrugPlus

60s Ribosomal Protein L22

Ensembl ID : ENSSTUG00000042420
Gene Symbol: LOC115166274
3 Cross references
207 Possible Orthologues:

60s Ribosomal Protein L22

Ensembl ID : ENSSTUG00000051240
Gene Symbol: LOC115207726
2 Cross references
197 Possible Orthologues:

60s Ribosomal Protein L22-Like

Ensembl ID : ENSSTUG00000030036
Gene Symbol: LOC115168275
3 Cross references
207 Possible Orthologues:

60s Ribosomal Protein L23

Ensembl ID : ENSSTUG00000025426
Gene Symbol: LOC115171269
3 Cross references
225 Possible Orthologues:

60s Ribosomal Protein L23

Ensembl ID : ENSSTUG00000021106
Gene Symbol: LOC115199716
3 Cross references
224 Possible Orthologues:

60s Ribosomal Protein L23a

Ensembl ID : ENSSTUG00000008697
Gene Symbol: LOC115153798
3 Cross references
100 Possible Orthologues:

60s Ribosomal Protein L24

Ensembl ID : ENSSTUG00000017635
Gene Symbol: LOC115161294
3 Cross references
311 Possible Orthologues:

60s Ribosomal Protein L24-Like

Ensembl ID : ENSSTUG00000015666
Gene Symbol: LOC115155900
3 Cross references
313 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSSTUG00000046141
Gene Symbol: LOC115205635
3 Cross references
472 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSSTUG00000000591
Gene Symbol: LOC115168162
3 Cross references
472 Possible Orthologues:

60s Ribosomal Protein L27

Ensembl ID : ENSSTUG00000005632
Gene Symbol: LOC115171473
3 Cross references
363 Possible Orthologues:

60s Ribosomal Protein L27

Ensembl ID : ENSSTUG00000018229
Gene Symbol: LOC115203001
3 Cross references
365 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).